Norway vs Sweden: Share of E. coli infections resistant to cephalosporins
Norway
5.1%
in 2021
Sweden
7.3%
in 2022
Norway rank
46th
Sweden rank
44th
Share of E. coli infections resistant to cephalosporins over time
- Norway
- Sweden
How they compare
Sweden currently reports 7.3% against 5.1% in Norway, a difference of 2.2%.
That makes Sweden's figure about 1.4 times Norway's.
Across all 5 years both countries report, Sweden has been ahead every year.
Norway ranks 46th and Sweden ranks 44th of 46 countries.
Sweden has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Norway | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6.0% | 7.8% | 1.7% | Sweden |
| 2020s | 5.2% | 7.3% | 2.1% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Norway or Sweden?
- Sweden, at 7.3% against 5.1% in Norway as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Norway and Sweden?
- 2.2%, with Sweden ahead.
- How many years of comparable data are there for Norway and Sweden?
- 5 years are reported by both, from 2017 to 2021.
- How do Norway and Sweden rank globally for share of e. coli infections resistant to cephalosporins?
- Norway ranks 46th and Sweden ranks 44th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).